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Abstract
The 2014-2015 Ebola epidemic in West Africa is the largest ever recorded, with over 27,000
cases and 11,000 deaths as of June 2015. The public health response was challenged by diffi-
culties with disease surveillance (particularly in more remote regions), which impacted subsequent
analysis and decision-making regarding optimal interventions. We developed a stage-structured
model of Ebola virus disease (EVD). A key feature of the model is that it includes a generalized
correction term accounting for factors such as the fraction of cases reported and fraction of the
population at risk (e.g. due to contact patterns, interventions, spatiotemporal spread, pre-existing
immunity, asymptomatic cases, etc.). We generated a range of short term forecasts for Guinea,
Liberia, and Sierra Leone, which we then validated using subsequent data. We also used the model
to examine the uncertainty in the relative contributions to transmission by the different stages of
infection (early, late, and funeral). We found that a wide range of forecasted trajectories fit ap-
proximately equally well to the early data. By including the correction factor term, however, the
best-fit models correctly forecasted EVD activity for all three countries, both individually and for all
countries combined. In particular, the models correctly forecasted the slow-down and stabilization
in Liberia, as well as the continued exponential growth in Sierra Leone through November 2014.
Parameter unidentifiability issues hindered estimation of the relative contributions of each stage of
transmission from incidence and deaths data alone, which poses a challenge in determining optimal
intervention strategies, and underscores the need for additional data collection. Even with these
limited data, however, it is still possible to accurately capture and predict the epidemic dynamics by
using a simplified correction term that approximately accounts for the complex underlying factors
driving disease spread.
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1 Introduction
Ebola virus disease (EVD) was first identified in 1976, in two simultaneous outbreaks in Sudan
and the Democratic Republic of the Congo [1]. The 2014-2015 Ebola epidemic is unprecedented
in both its size and complexity, exceeding the numbers of cases and deaths for all previous Ebola
outbreaks combined [2]. The outbreak began in Guinea in December 2013 [3], expanding to yield
widespread and intense transmission in Guinea, Liberia, and Sierra Leone, as well as cases in
seven additional countries (Italy, Mali, Nigeria, Senegal, Spain, UK, USA) [4]. The devastation
of the 2014-2015 Ebola epidemic in West Africa presented the public health community with
many surprises and many challenges. Unparalleled explosion of cases within urban regions and
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Figure 1: Progression of EVD from exposure, through onset of symptoms, worsening, and eventually death.
in a new part of Africa was unexpected; the Ebola virus’ ecologic niche was the exploitation of a
combination of urbanization, regional instability, extreme poverty and insufficient infrastructure
to contain spread [5]. The challenges associated with containment have been varied and included
accurate reporting of cases and deaths; accurate tracking of behavioral changes that put people
at increased or decreased risk, and accurate assessment of conferred immunity within the pop-
ulation. These and other factors associated with surveillance, behavior patterns affecting risk,
and biological patterns affecting risk vary over time and impact how well incidence patterns are
estimated.
The difficulties of surveillance have resulted in frequent reclassification and changes in case
reporting as the outbreak evolved [4]. Reporting fraction estimates have been difficult, although
some have been presented [6, 7]. Often regions were lacking in laboratory capacity to confirm
cases, which when combined with widespread underreporting [6, 8] results in the potential for
wide variation in reporting fraction with either over- or under-estimates of cases. Rural areas in
particular saw significant difficulties in both data collection and healthcare response [9]. The lev-
els of asymptomatic infection and preexisting immunity are also largely unknown for the current
outbreak, and have been noted as factors which can lead to overestimation of incidence when fore-
casting [10]. Additionally, behavior change has been noted as a major factor affecting the course
of the epidemic, and ultimately helping to curtail it [11, 12], however there is little quantitative
data on behavioral changes over time. Clearly, good surveillance requires appropriate mechanisms
to collect data on these issues of reporting, behavior, and population immunity. Although we
aspire to collect better and more complete data, in the midst of an outbreak data collection is
often not and arguably should not be considered a priority over providing health care.
There have been a wide range of simulation models developed for EVD in recent months
to assist in decision-making and public health response efforts [6, 10, 13–22], many of which
are based on early models by Chowell, Legrand, and others [23–25]. Several models have been
used for forecasting and for understanding disease dynamics [6, 10, 13, 15], disease progression
and immunity [10, 22], and evaluating alternative interventions [16, 26]. In this manuscript,
we add to this growing literature by presenting a stage-structured model of EVD transmission,
where we incorporate a correction term that broadly accounts for the fraction of cases and deaths
reported, as well as the symptomatic fraction, pre-existing immunity levels, and other components
determining the overall fraction of the population at risk. This correction factor provides a simple
parametric adjustment by which we can account for limitations common in data sparse outbreak
settings, allowing us to accurately capture and predict the epidemic dynamics.
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Figure 2: Stage-structured compartmental model of EVD, which splits the population into susceptible (S),
exposed (E), first-stage infected (I1), late-stage infected (I2), recovered R, and funeral transmissible (F ).
Red compartments are transmissible, and recovery rates are greater from I1 than from I2 [28].
2 Data
Cumulative incidence of suspected cases and deaths from Guinea, Liberia, Sierra Leone, and all
countries combined as reported by the World Health Organization (WHO) [4] from May 2014
to February 2015 was used in this analysis. In estimating the model parameters, we used start
dates roughly corresponding to when each location began consistent exponential growth, to avoid
issues due to initial stochasticity and hurdles in setting-up reporting systems (e.g. some early
data shows decreases in cumulative cases, likely due to changes in surveillance systems, case
definitions, etc.), as shown in the Figures. For the end dates for used in parameter estimation, we
note that intervention efforts escalated significantly after October 1, 2014, including the beginning
of the first-ever UN emergency health mission, the UN Mission for Ebola Emergency Response
(UN-MEER) on October 1, 2014 [27]. Additionally, the data beginning in October had increased
uncertainty and changes in reporting, with incomplete data and significant decreases in reported
cumulative cases (likely due to changes in reporting) [4]. A WHO Roadmap update from October
stated that “the capacity to capture a true picture of the situation in Liberia remains hamstrung
by underreporting of cases” [8]. Thus, we primarily fitted data up through October 1, 2014, and
used the subsequent data for validation, as described below.
3 Methods
3.1 Model Structure
EVD is transmitted by contact with body fluids [1, 29], with the overall course of EVD infection
shown in Figure 1. Healthcare workers are at particular risk for transmission due to their frequent
contact with patients and body fluids. Burial ceremonies during which mourners contact the
body of the deceased have also been identified as playing an important role in community-based
transmission [1, 29, 30]. EVD has an average incubation period of 8-10 days (range of ∼2-21 days),
with individuals believed to become infectious after the onset of symptoms [1]. EVD progresses
in two broad stages—an initial infectious stage (I1) in which symptoms tend to be milder (such
as fever, headache, sore throat, muscle aches), often progressing to diarrhea, vomiting, and a
second, more intense stage (I2) during which these as well as more advanced symptoms (such
as hemorrhaging and multi-organ failure) manifest [1, 28]. Typical time to progression between
infection stages is approximately 5-7 days [31]. As second stage symptoms tend to have more
release of body fluids, transmissibility increases as the disease progresses [30]. Most recoveries
occur from the first stage, while the second stage is often fatal [28, 31–33]. Among fatal cases,
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death occurs 6-16 days after symptom onset (averaging 7.5 days for the 2014 outbreak) [31]. Thus,
we used a two-staged infection process to reflect the increasing symptoms and transmissibility as
the infection progresses [1, 28], with death occurring after symptom progression to the second
stage (I2). The model structure is shown in Figure 2 and the model equations are:
dS
dt
= −(βII1 + β2I2 + βFF )S
dE
dt
= (βII1 + β2I2 + βFF )S − αE
dI1
dt
= αE − γ1I1
dI2
dt
= δ1γ1I1 − γ2I2
dF
dt
= δ2γ2I2 − γFF
dR
dt
= (1− δ1)γ1I1 + (1− δ2)γ2I2 − γRR
(1)
where S is the fraction of the population which is susceptible, E the fraction exposed, I1 the
fraction in the first stage of infection, I2 the second stage of infection, R the fraction of the
population which is recently recovered (i.e. who would still require a bed if hospitalized), and
F , the fraction of the population that has died and is in the process of being buried. Because
we considered a relatively short time frame (< 1 year), for simplicity we ignored population
background births and deaths.
The parameter δ1 represents the fraction of infected who progress to I2 and δ2 the fraction
who subsequently progress to death, with δ = δ1 · δ2 thus defined as the overall fraction of cases
resulting in death (case fatality risk (CFR)). As the overall CFR is a more commonly measured
quantity than the progression rate from I1 to I2, we primarily worked using δ rather than δ1
(setting δ1 = δ/δ2).
The model structure is somewhat similar to the SEIHFR model of Legrand et al. [24], in which
infected individuals in the community (I) can be admitted to the hospital (H), however the pro-
gression in this model is through the natural history of the disease rather than from household to
hospital. Thus, there are different mechanistic assumptions underlying the two models, so that
even though the resulting compartmental diagrams are similar, there are important differences in
the flows between compartments. For example, SEIHFR models typically assume lower transmis-
sion rate parameters in the hospital (H) stage [16], which contrasts with the higher transmission
rate parameters in the second stage of infection used in our model; additionally, mortality is
significantly higher for infected individuals in the community than in the hospital, whereas there
is higher recovery in the first stage and death only after the second stage of infection in our model.
Basic Reproduction Number. Using the second-generation matrix approach [34, 35], the basic
reproduction number for the model is given by:
R0 = β1
γ1
+
β2δ1
γ2
+
βF δ1δ2
γF
. (2)
where R0 for the system breaks into three portions based on each transmission stage, weighted
by the fraction of individuals who reach that stage and the amount of time spent in each stage
(as is typical for stage structured models [35]).
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Measurement Equations. To connect the model to the data on cumulative cases and deaths
provided by the WHO, we append the following measurement equations to Eq. (1):
yC = kN
∫ t
0
αEdτ,
yD = kN
∫ t
0
δ2γ2I2dτ,
(3)
where yC represents cumulative cases, and yD cumulative deaths. The parameter k represents a
combination of several factors, including: the fraction of the population at risk (whether due to
social contact structure, spatial heterogeneity, immunity from asymptomatic infection, or other
factors), a rough correction for errors in our initial condition assumptions, and the fraction of
cases and deaths reported (reporting fraction). Although in reality the reporting fraction is likely
to be different for cases and deaths, it is not known how or in which direction, so for simplicity
we set the two to be equal.
3.2 Parameter Estimation Methods
Table 1 gives the parameter definitions, values, ranges, and sources. For the total population
size, N , we used a total population of 11,745,189 for Guinea, 4,294,077 for Liberia, and 6,092,075
for Sierra Leone, as determined by the World Bank [36]. The model initial conditions were
approximated from the data as described in the Supplementary Information.
To fit the model, we used least squares fitted to cumulative cases and deaths as reported by the
WHO via the measurement equations (3), using Nelder-Mead optimization in MATLAB [37]. We
would expect that a wide range of model parameters may fit the data equally well—particularly
as the data up through October 1 was still in the exponential growth phase, during which it can
be fitted with only two parameters (i.e. as one would fit a line on a log scale). Fitting to cumula-
tive incidence measurements has been shown to potentially result in artificially small confidence
bounds on parameter estimates and forecasts [38], although the potential unidentifiability due to
exponential growth-phase data means there may be a large or even infinite range of parameter
values that fit the data well, for both cumulative or daily incidence. We used cumulative incidence
in our analyses because at the time of the outbreak, cumulative incidence was reported rather
than daily case counts [4], and the cumulative incidence provided often decreased significantly
from one time point to another (due to reclassification and changes in reporting). Differencing to
yield non-cumulative incident cases would thus generate some negative case counts.
To address both the issue of artificially smaller confidence intervals due to the use of cumulative
incidence data, and the fact that the data are largely exponential (yielding inherent identifiability
issues in fitting), we used a Latin Hypercube (LH) sampling approach. We sampled all parameters
across realistic ranges given in Table 1, and then for each sample, we fit only two parameters, the
transmission parameter β1 and the overall mortality fraction δ. We note that all of the sampled
regions could generate qualitatively good fits that were consistent with the observed data once
β1 and δ were fitted. Thus, the method allows us to examine the full range of parameters and
model trajectories consistent with both the data and the known realistic ranges of the parameters.
We then used these bounds rather than traditional confidence intervals for our forecasting and
estimates. Essentially, this method uses the biological ranges for the parameters to generate our
ranges of estimates for the parameters and forecasts, rather than likelihood-based criteria, which
may suffer from issues of unidentifiability and lack of independence in the data. Since realistic
values for k are largely unknown (as k accounts for a wide range of factors), the range for k
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Definition Units Range Source
β1
Transmission parameter for first
stage of illness
people−1 days−1 Estimated Estimated
β2
β1
Ratio of infectiveness in first vs.
second stage of illness
unitless 1.5 - 5 [22, 30, 39]
βF
β1
Ratio of infectiveness in first
stage vs. funeral transmission
unitless 1.5 - 5 [16, 22, 30, 39]
α−1 Average incubation period days 8-10 [1, 29]
γ−11
Average length of first stage of
illness
days 5 - 7 [1, 28]
γ−12
Average length of second stage
of illness
days 1 - 2 [1, 28]
γ−1F
Average time from death until
burial
days 1 - 3 [1, 16]
γ−1R
Average duration of ETU bed
occupancy after recovery
days 5 - 15 [6],∗
δ Overall mortality fraction unitless Estimated Estimated
δ2
Mortality fraction among those
in second stage of illness
unitless 0.9 - 1 [28]
k
Fraction of the population at
risk, symptomatic fraction, and
reporting fraction
unitless 0.001 - 1† See methods
Table 1: Model parameters, definitions, units, sources, and ranges used in the simulations. ∗Personal
communication with clinicians on the ground in Liberia. †This range was used for all simulations except
when fitting Guinea in Figure 3, where a wider range from 0.00025 - 1 also yielded equally good fits to the
data and was used. ETU = Ebola treatment unit.
was set very broadly, with an upper bound of 1 (representing perfect reporting and a completely
at-risk population) and an approximate lower bound determined by taking the lowest value which
still yielded qualitatively good fits. We LH-sampled 1000 parameter sets for each of four cases:
all countries combined, Guinea, Liberia, and Sierra Leone. We also tested the extrema of each
range in Table 1, to illustrate the full range of potential behaviors generated by the model in the
realistic ranges.
4 Model Simulations
4.1 Fitting and Forecasting
Table 2 shows the estimated values for β1, δ, and R0 for each data set. The remaining LH
sampled (non-fitted) parameters that resulted in the overall best fit in Table 2 are given in the
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Overall Range of
Parameter Best Estimate Estimates (Median)
A
ll
C
o
u
n
tr
ie
s
β1 0.11 0.079 - 0.18 (0.12)
δ 0.56 0.55 - 0.6 (0.57)
R0 1.60 1.43 - 1.64 (1.53)
G
u
in
ea
β1 0.16 0.078 - 0.18 (0.11)
δ 0.65 0.64 - 0.72 (0.68)
R0 1.79 1.47 - 1.79 (1.61)
L
ib
er
ia
β1 0.12 0.0725 - 0.17 (0.10)
δ 0.63 0.63 - 0.72 (0.67)
R0 1.81 1.34 - 2.75 (1.47)
S
ie
rr
a
L
eo
n
e
β1 0.12 0.085 - 0.17 (0.12)
δ 0.38 0.36 - 0.38 (0.37)
R0 1.32 1.19 - 1.37 (1.25)
Table 2: Estimated values for β1, δ, and R0, using the stage structured model. All remaining parameters
were LH sampled from the ranges in Table 1. The overall best fit values of β1 and δ across all samples are
given in the middle, and the range and median of estimates are given in the right column.
Supplementary Information. Since γR does not affect the model goodness-of-fit (since recovered
individuals are assumed not to transmit the virus), we took γR to be the midpoint of the range
in Table 1 for the best-fit simulations.
Figure 3 shows the fits to data with projections of the numbers of cases, deaths, and beds
needed through December 1, 2014. The number of beds needed was calculated as the total in-
fected and recently recovered, kN(I1+I2+R) (though we note that k includes the reporting rate,
so that the true number of beds needed may be larger). The model predictions showed a wide
range of potential trajectories (grey shaded regions), with the overall best fit trajectory shown as
a solid line. For comparison purposes, we also show the reported data for cases and deaths from
October (red +’s), and from November (orange +’s), although we note that our model projections
did not explicitly account for changes in reporting rate or effects of interventions, both of which
are known to have been significant during October and November [4, 27]. In particular, there
are several sudden increases and decreases in the cumulative case data that are due to changes in
reporting [4], which the model does not capture as we use a constant reporting rate (in particular,
the model cannot capture decreases in cumulative cases). Nonetheless, the forecast from the LH
sampled best-fit trajectory (red line) was generally close to the reported data, and captured the
correct qualitative behavior in all cases (i.e. continued exponential growth vs. slowing down of
the epidemic). The forecasts matched the first month of data (red +’s) quite closely, with wider
deviations in comparing with the second month of data (orange +’s). In particular, the model
was able to correctly forecast the downturn in Liberia but continued exponential growth in Sierra
Leone.
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Figure 3: Model fit to total cumulative cases and deaths up through October 1, 2014. Grey region shows
the full range of best-fit trajectories for the parameter ranges in Table 1. The model dynamics using overall
best fit parameters across all LH-sampled values is shown in red. Data used for fitting is shown as circles,
subsequent data not used for fitting shown as red +’s for October and orange +’s for November.
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Parameter Uncertainty and Transmission by Stage. We note that the full ranges of LH-sampled
parameter values in Table 1 yielded similarly good fits, showing the expected practical uniden-
tifiability of the parameters when fitting to largely exponential growth phase epidemic data.
Supplementary Figure S1 shows histograms of the residual sum of squares values for all fits. The
trajectories with the lowest squared residuals did tend to cluster near the best fit line in Figure 3,
as shown in Supplementary Figure S2 (which shows the best 10% of all LH-sampled fits). Among
these best 10% of fits, most of the LH-sampled parameters show broad ranges covering the full
bounds given in Table 1, illustrating that the parameter uncertainty/unidentifiability persists
when only the best goodness of fit scores are considered (Supp. Fig. S3).
In particular, a wide range of values for the transmission parameters by stage were able to
generate very similar fits and forecasts. This suggests these parameters may form a practically
identifiable combination [40, 41], wherein decreases in transmission levels in one stage can be
compensated for by increasing transmission in another stage, so that the individual transmis-
sion parameters cannot be estimated (are unidentifiable), but the overall transmission level is
estimable. This compensation manifests in parameter space as an approximate plane of best fit
parameter estimates, shown in Figure 4.
The parameter uncertainty also results in large uncertainty in the contributions of each stage
to R0. The model R0 breaks up naturally into terms for each of the three stages (with each
term in Eq. (2) corresponding to I1, I2, and F ), representing the relative contributions of each
transmission stage to R0. Each term can be interpreted as the average number of secondary
cases generated by an infectious individual while in a particular stage of transmission. For both
the full set of LH-sample fits and the best 10% of fits, a similarly wide range of contributions by
stage for R0 were found, as shown for all countries combined in Supplementary Figure S4 and
Supplementary Table S1. Further discussion of the uncertainty in parameters can be found in
the Supplementary Information.
Reporting and Population at Risk. The parameter k was responsible for the much of the breadth
in the forecasted trajectories for cumulative cases and deaths in Figure 3. In general, the forecasts
from a single set of parameters could be adjusted to cover the full shaded range of forecasted cases
and deaths just by changing k and re-fitting β1 and δ, with lower values of k corresponding to
earlier deviation from exponential growth and epidemic slowdown (due to exhaustion of suscep-
tibles as the effective population at risk is smaller), and the top edge of the grey shaded regions
representing the model fit without including k (i.e. with k = 1). The overall best fit trajectories
shown in red in Figure 3 coresponded to LHS sampled values for k that were quite low for the all
countries combined, Guinea, and Liberia cases (k = 0.0026, 0.0006, and 0.0024 respectively), but
not for Sierra Leone (k = 0.68), correctly forecasting epidemic slowdown in the first three cases,
with continued exponential growth in Sierra Leone. As k includes both the reporting rate and
fraction of the population at risk, we hypothesize that k provides a simplified way to account for
interventions, existing immunity, and changes in behavior, which can effectively act to shrink the
population at risk.
4.2 Expanded Fitting and Forecasting Simulations
To evaluate the importance of including k when forecasting, we generated multiple fits and fore-
casts with k either included or not included in the model. For these fits, for simplicity we fixed all
parameters to the midpoints of the ranges in Table 1, and then fit β1, δ, and either fit k or fixed
k = 1 (equivalent to not including k in the model). We fit the models to data sets up through
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Figure 4: Top row: front (left) and side (right) views of the estimates of β1, β2/β1, and βF /β1 for all
countries combined (Fig. 3), with the best-fit plane shown as a mesh. The three parameters have an
approximately linear relationship with one another, indicating that the parameters may be unidentifiable
individually, but identifiable in combination. Bottom row: left panel shows contour lines of β2/β1 and
βF /β1 for fixed values of β1, and right panel shows a scatterplot of β2/β1 and βF /β1 for a roughly fixed
value of β1 between 0.115 and 0.12. Both panels highlight the approximately linear compensation between
β2 and βF , such that similarly good fits can be obtained for a wide range of values, so long as roughly the
same total transmission level is maintained.
the first of the month for July, August, September, October, November, and December, and then
forecast the subsequent two months (so the forecasts were until Sept. 1, 2014 - Feb. 1, 2015).
As shown in Figure 5 for all countries combined, the models with and without k performed
quite similarly until the data from September 2014 is included in the fit, at which point the
model with k outperformed the model without k (i.e. where k is fixed at 1). In particular, the
model with k was able to predict and capture the downturn in cases and deaths, while the model
without k consistently over-forecasts the number of cases and deaths. The resulting parameter
estimates (Table 3) show relatively consistent estimates for β1 and δ across the length of data
and value or inclusion of k in the model. When included in the model, the fitted value of k was
larger during the period of exponential growth and then dropped by two orders of magnitude
once the data began to show indications of epidemic slowdown. Supplementary Figures S5 and
S6 and Supplementary Tables S2 and S3 show similar results for each of the individual countries
as well. While the model with k sometimes over- or under-forecasted, it did not suffer from the
consistent over-forecasting generated seen when k was not included. We also tested a fixed value
of k = 1/2.5 to account only for underreporting as estimated in [6], which we found yielded
very similar results to the model without k included (k = 1), as shown in Supp. Figure S7 and
Supp Table S7. These results appeared to depend primarily on the inclusion of k rather than the
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Figure 5: Multiple model fits and forecasts generated either with k included (top row) or not included
(equivalent to fixing k = 1, shown bottom row). The model fits (solid lines) use the data up through July
1 (red), August 1 (orange), September 1 (yellow), October 1 (green), November 1 (blue) and December 1
(purple), with subsequent two months of forecasts shown as dashed lines in the same color. Both models
with and without k forecast similarly for the early data (red, orange, and yellow forecasts), after which
point the model with k performs better (green, blue, purple forecasts). Note the different y-axis scales in
the top row vs. the bottom row.
particular model structure used here, as preliminary tests using a simplified form of the model
with only a single infectious stage (i.e. the SEIRD model [42]) generated similar forecasts when
k was included vs. not included (not shown).
It is notable that the data for Liberia, Guinea, and the all countries combined cases showed
earlier epidemic slowdown in 2014, whereas the Sierra Leone data showed continuing exponential
growth through all data used in fitting (through December 2014). The forecasts and parameter
estimates for the model including k reflected this pattern, with estimates for k for Guinea, Liberia,
and all countries combined dropping by two to three orders of magnitude once the data through
October 1, 2014 was included (Tables 3 and S2), corresponding to slowed forecasts as well. By
contrast, the estimates for Sierra Leone stayed larger (k ranged from 0.34 to 0.73) for all fits,
corresponding to continuing projections of exponential growth. Because of these larger estimates
due to continuing exponential growth, the forecasts for Sierra Leone were similar to those using
fixed values of k (Figures S2, S6, and S7).
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Estimates with k Without k
Using data through: β1 δ k β1 δ
July 1, 2014 0.14 0.69 0.26 0.14 0.69
Aug 1, 2014 0.12 0.67 0.31 0.12 0.67
Sep 1, 2014 0.13 0.64 0.38 0.13 0.64
Oct 1, 2014 0.14 0.57 0.0018 0.13 0.58
Nov 1, 2014 0.14 0.51 0.0018 0.13 0.53
Dec 1, 2014 0.16 0.43 0.0015 0.14 0.45
Table 3: Parameter estimates for each fit in Figure 5, both with k included (left) and without k (i.e. with
k fixed = 1). Each model is fitted to the data up through the dates given on the left.
5 Discussion
Forecasting under conditions presented in the current Ebola outbreak will always be challenged by
uncertainty in the data. As much as we would like to insist on better quality data, the immediacy
of public health demands will always be of primary importance for the health care workers on the
ground. Analytical approaches need to be able to address uncertainty and unidentifiability while
still providing useful information to public health officials working to mitigate the outbreak. In
the case of the Ebola outbreak, uncertainties centered around reporting and lack of knowledge of
numbers at risk necessitated an approach to account for these unknown factors. In spite of large
uncertainty and an absence of detailed data, model forecasts can still provide useful predictions
of the behavior of the epidemic by using a simplified correction term.
Forecasting and the Correction Factor k. A key finding was that in spite of the large uncertainty,
the best-fit models that included the reporting rate/population-at-risk parameter k were able to
successfully forecast the numbers of reported cases and deaths up to two months ahead (Figures
3, 5, and Supp. Figure S5), while models without k (Figs. 5 and S6) or using a k value based
on reporting rate estimates alone (Fig. S7) consistently overestimated the incidence as they were
unable to capture the slowing of the epidemic away from exponential growth. We propose that
k provides an ad hoc way to represent the effects of changing conditions on the ground, shifts
in behavior in the population, and ongoing intervention efforts. As interventions and changes in
behavior reduce transmission, this may reduce the effective population at risk (decreasing k), so
that the overall epidemic burns out earlier than it otherwise would (i.e. with increasing protection
from transmission viewed as whole or partial removal from the population at risk). A lower value
of k thus results in a fitted model with a rapid increase matching the exponential growth in the
data, followed by an earlier epidemic turn over/burn out due to the smaller effective population
at risk, which would not be possible if the model treated the full population as at-risk (since the
rapid early growth would correspond to a much larger epidemic).
The usefulness of k in forecasting is particularly evident when comparing the patterns seen in
the data for each country. The data for Liberia, Guinea, and all countries combined shows slowing
of the epidemic from exponential growth much earlier (late 2014), while Sierra Leone continued to
show exponential growth through the end of 2014 and into 2015 [4]. This pattern was difficult for
many models to distinguish and predict [43–45] (although we note that most models were worst-
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case estimates and were not intended to account for how changes in reporting or interventions
would affect the epidemic trajectory, as discussed further by Rivers et al. [46]). However, when
k was included, the model forecasted these qualitative differences between countries correctly.
Correspondingly, the fitted and LH-sampled k values for Guinea, Liberia, and all countries were
two orders of magnitude smaller once the September data was included, but estimates for Sierra
Leone remained large (Tables 3 and S2). This suggests that even though the slow-down may
not be immediately evident by eye as of October 1, 2014, the upcoming change in dynamics was
preluded in the data, and subsequently captured by the best-fit models.
Parameters similar to k are often used to account for the reporting fraction [47–49]; alter-
natively it is also common to re-scale or adjust the data to account for underreporting [50, 51].
However, correction parameters such as the k used here are not often considered explicitly for
representing other factors such as the population at risk and symptomatic fraction seen here (al-
though similar issues of saturation have been noted and examined in other ways [52]). A related
modeling study [10] recently showed that forecasts will tend to overestimate incidence of EVD
if asymptomatic infections and their resulting immunity are not taken into account, which illus-
trates a similar phenomenon to that observed here. It is of interest to note that one of the most
commonly observed identifiable combinations in SIR-type models is between the reporting rate
and total population size [48, 49, 53], making such a combined parameter natural to consider. In
previous work we explicitly used k to correct for the population at risk in the context of cholera
[53, 54], but here we extend these results to evaluate the effects of this correction parameter on
forecasting have been examined.
There are a wide range of factors which may alter the value of k and the apparent population
at risk, including underreporting, asymptomatic infections, pre-existing immunity, social contact
structures, spatial spread, behavior patterns, and ongoing interventions. As many of these factors
are likely to be at work in outbreak settings we would expect that, without any adjustment or
accounting for these issues, most models will tend to over-forecast. Our results show that even
the extremely simplified and agglomerated adjustment used here can make a significant difference
the accuracy of the model forecasts. However, it is important to note that this approach does
not mechanistically account for these factors, so that if there is no evidence of saturation of the
epidemic in the data, even models including k can over-estimate, as illustrated in the last forecast
for Sierra Leone in Supplementary Figure S5. All of these factors would also be expected to
change over time, making it difficult to generate long-term predictions—we were able to accurately
forecast up to two months ahead using this constant factor, but more explicitly mechanistic
models might be helpful for more accurate longer-term predictions. In general, some factors may
change over time in ways which a simple correction term cannot account for—the trajectory of
the Guinea data over 2014-2015 shows an extended, nearly-linear growth period, and occasional
plateaus, which this approach may not completely capture depending on what data is used for
forecasting. Indeed, the the forecasts for Guinea seen in Supplementary Figure S5 show some
cases of both over- and under-prediction, although the forecasts remain significantly better than
those without k or using k = 1/2.5.
Additional data on the factors making up k would allow us to understand their relative im-
portance in the epidemic dynamics, and may help further improve forecasting by understanding
how these components are likely to change. Forecasting efforts are often useful for comparing
outcomes from alternative scenarios with varying interventions. Understanding the uncertainty
inherent in these forecasts can itself be useful in evaluating the range of intervention efforts that
may be needed based on current data, and could potentially help guide additional data collection
efforts to reduce this uncertainty [55]. Comparative modeling approaches may also be helpful in
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this process [55], as different model structures and approaches may result in further uncertainty,
or potentially provide some consensus across a range of different model assumptions.
Uncertainty & Unidentifiability. That the full range of the sampled parameters fit the data simi-
larly well but yielded a wide range of forecasted trajectories (shaded regions in Figure 3) illustrates
the expected uncertainty and parameter unidentifiability associated with forecasting from expo-
nential growth phase data, in which a range of parameter values can yield the same initial growth
rate, but may differ as to when their resulting trajectories begin to slow from exponential growth.
This idea has been used to develop simple two-parameter predictive models of the epidemic, as
demonstrated by Fisman et al. [18]. This practical unidentifiability of the model results in iden-
tifiable combinations of parameters, so that increasing the transmission parameter of one stage
can be compensated by decreasing that of another stage (as shown in the approximate plane of
best fit parameter estimates in Fig. 4). This issue has also been noted for infected and funeral
transmission by Weitz and Dushoff [42], using the SEIRD model, wherein they also note that the
unidentifiability issues are likely to persist more broadly in models fitted to exponential growth
data, as is indeed the case here. Unidentifiability of transmission parameters has also been noted
to be a common issue more generally [53, 56–58]. Transmission parameters are often difficult to
measure empirically, so that a lack of identifiability may hinder estimates of the magnitudes of
different transmission pathways or terms of R0 (Supp. Fig. S4 and Supp. Table S1). This can
make it difficult to inform decision-making between alternative intervention strategies focused on
different transmission pathways (e.g. increasing safe burials vs. building ETUs). Additional data
collection that distinguishes transmission pathways (e.g. on behavioral and contact patterns,
burial practices, etc.) is thus important to improve parameter identifiability and make modeling
efforts more practically applicable to decision-making.
Limitations & Future work. The model does not account for factors such dynamic changes in
reporting, differences in reporting between cases and deaths, or effects of spatial spread and
mobility (all likely changing with time). Changing conditions on the ground made forecasting
further than 1-2 months ahead a difficult task (as illustrated in Figures 3 and 5), and further
work to capture these time-varying parameters is warranted. Similarly, while the parameter k may
capture the effects of behavior change on the population at-risk in a rough way, deeper exploration
of how behavior and contact patterns shifted over the course of the outbreak (particularly related
to hygiene and funeral practices) is important, both for modeling and data collection efforts.
Another direction for future work is in examining the stage structure of the clinical course of
EVD in more detail. This model includes a simplified representation of the natural history of
EVD using two stages. However, some descriptions of EVD break the clinical course into three or
more stages, for example, as described by Beeching et al. [32]: “a few days of non-specific fever,
headache, and myalgia, followed by a gastrointestinal phase in which diarrhoea and vomiting,
abdominal symptoms, and dehydration are prominent. In the second week, the patient may
recover or deteriorate, with a third phase of illness including collapse, neurological manifestations,
and bleeding, which is often fatal.” Our model likely includes part of this gastrointestinal phase
in each of the two stages, and further work expanding the stage structure would be useful,
particularly in evaluating the potential for stage-driven interventions. The complex dynamics of
the viral load and immune response have recently begun to be explored in modeling efforts [22],
and further work in this area would be particularly useful for uncovering clinical features that
can be used to optimize treatment approaches.
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Conclusions
Explicitly accounting for under-reporting and fraction of population at risk can improve forecast-
ing even when the uncertainty in predictions and parameter estimates are high. Specifically, we
found that a scalar correction factor was identifiable and correctly forecasted the discrimination
between continued exponential growth of cases in Sierra Leone through 2014 versus early leveling
off in Liberia and Guinea.
Acknowledgements
This work was supported by the National Institute of General Medical Sciences of the National
Institutes of Health under Award Number U01GM110712 (supporting JNSE, MCE, RM, and
EVW), as part of the Models of Infectious Disease Agent Study (MIDAS) Network. The content
is solely the responsibility of the authors and does not necessarily represent the official views of
the National Institutes of Health.
Competing interests
The authors declare that we have no competing interests.
Authors’ Contributions
MCE designed the study, performed all model simulations and analyses, contributed to the col-
lection of online data sources, and drafted and revised the manuscript. MCE and JPD developed
the initial model, with substantial revision by all authors to form the final model. JPD led the
collection of online data sources, and provided critical revisions to the manuscript for intellec-
tual content. JNSE, EVW, SC, YK, and RM provided critical revisions to the manuscript for
intellectual content. All authors gave final approval for publication.
References
[1] World Health Organization, “Ebola Virus Disease Fact Sheet, updated September 2014. http://www.
who.int/mediacentre/factsheets/fs103/en/.”
[2] WHO Ebola Response Team, “Ebola virus disease in west africa the first 9 months of the epidemic
and forward projections,” New England Journal of Medicine, vol. 371, no. 16, pp. 1481–1495, 2014.
PMID: 25244186.
[3] S. Baize, D. Pannetier, L. Oestereich, T. Rieger, L. Koivogui, N. Magassouba, B. Soropogui, M. S.
Sow, S. Ke¨ıta, H. De Clerck, et al., “Emergence of zaire ebola virus disease in guinea,” New England
Journal of Medicine, vol. 371, no. 15, pp. 1418–1425, 2014.
[4] World Health Organization, “Ebola response roadmap - Situation report, http://www.who.int/csr/
disease/ebola/situation-reports/en/,” 2014.
[5] K. Alexander, C. Sanderson, B. L. M. Marathe, C. Rivers, J. Shaman, J. Drake, E. Lofgren, V. Dato,
M. Eisenberg, and S. Eubank, “What factors might have led to the emergence of ebola in west africa?,”
PLOS Neglected Tropical Diseases, vol. In press, 2014.
15
[6] M. I. Meltzer, C. Y. Atkins, S. Santibanez, B. Knust, B. W. Petersen, E. D. Ervin, S. T. Nichol, I. K.
Damon, and M. L. Washington, “Estimating the Future Number of Cases in the Ebola Epidemic —
Liberia and Sierra Leone, 2014-2015,” MMWR Surveill Summ, vol. 63, pp. 1–14, 2014.
[7] S. V. Scarpino, A. Iamarino, C. Wells, D. Yamin, M. Ndeffo-Mbah, N. S. Wenzel, S. J. Fox,
T. Nyenswah, F. L. Altice, A. P. Galvani, et al., “Epidemiological and viral genomic sequence analysis
of the 2014 ebola outbreak reveals clustered transmission,” Clinical Infectious Diseases, p. ciu1131,
2014.
[8] World Health Organization, “Ebola response roadmap - Situation report, October 29,
2014, http://apps.who.int/iris/bitstream/10665/137376/1/roadmapsitrep_29Oct2014_eng.
pdf?ua=1,” 2014.
[9] S. Dallatomasinas, R. Crestani, J. Squire, H. Declerk, G. Caleo, A. Wolz, K. Stinson, G. Patten,
R. Brechard, O. Gbabai, et al., “Ebola outbreak in rural west africa: epidemiology, clinical features
and outcomes.,” Tropical medicine & international health: TM & IH, 2015.
[10] S. E. Bellan, J. R. Pulliam, J. Dushoff, and L. Meyers, “Ebola control: effect of asymptomatic infection
and acquired immunity,” The Lancet, vol. 384, pp. 1499–1500, 2014.
[11] S. Funk, G. M. Knight, and V. A. Jansen, “Ebola: the power of behaviour change,” Nature, vol. 515,
no. 7528, pp. 492–492, 2014.
[12] L. Charbonneau and M. Nichols, “Reuters: Ebola outbreak in West Africa appears to be slowing down,
http://www.reuters.com/article/2015/01/15/health-ebola-un-idUSL1N0UU2QF20150115,”
Jan. 15, 2015.
[13] H. Nishiura and G. Chowell, “Early transmission dynamics of ebola virus disease (EVD), west africa,
march to august 2014,” Euro Surveill, vol. 19, no. 36, p. 20894, 2014.
[14] G. Chowell and H. Nishiura, “Transmission dynamics and control of ebola virus disease (evd): a
review,” BMC medicine, vol. 12, no. 1, p. 196, 2014.
[15] M. F. Gomes, A. P. y Piontti, L. Rossi, D. Chao, I. Longini, M. E. Halloran, and A. Vespignani,
“Assessing the international spreading risk associated with the 2014 west african ebola outbreak,”
PLOS Currents Outbreaks, 2014.
[16] C. M. Rivers, E. T. Lofgren, M. Marathe, S. Eubank, and B. L. Lewis, “Modeling the impact of
interventions on an epidemic of ebola in sierra leone and liberia,” PLOS Currents Outbreaks, vol. Oct
16, Edition 1, 2014.
[17] C. Browne, X. Huo, P. Magal, M. Seydi, O. Seydi, and G. Webb, “A model of the 2014 ebola epidemic
in west africa with contact tracing,” arXiv preprint arXiv:1410.3817, 2014.
[18] D. Fisman, E. Khoo, and A. Tuite, “Early epidemic dynamics of the west african 2014 ebola outbreak:
estimates derived with a simple two-parameter model,” Plos Currents Outbreaks, 2014.
[19] G. Chowell, C. Viboud, J. M. Hyman, and L. Simonsen, “The western africa ebola virus dis-
ease epidemic exhibits both global exponential and local polynomial growth rates,” arXiv preprint
arXiv:1411.7364, 2014.
[20] A. Pandey, K. E. Atkins, J. Medlock, N. Wenzel, J. P. Townsend, J. E. Childs, T. G. Nyenswah, M. L.
Ndeffo-Mbah, and A. P. Galvani, “Strategies for containing ebola in west africa,” Science, vol. 346,
no. 6212, pp. 991–995, 2014.
[21] M. A. Kiskowski, “A three-scale network model for the early growth dynamics of 2014 west africa
ebola epidemic,” Plos Currents Outbreaks, 2014.
16
[22] D. Yamin, S. Gertler, M. L. Ndeffo-Mbah, L. A. Skrip, M. Fallah, T. G. Nyenswah, F. L. Altice, and
A. P. Galvani, “Effect of ebola progression on transmission and control in liberia,” Annals of internal
medicine, 2014.
[23] G. Chowell, N. W. Hengartner, C. Castillo-Chavez, P. W. Fenimore, and J. Hyman, “The basic
reproductive number of ebola and the effects of public health measures: the cases of congo and
uganda,” Journal of Theoretical Biology, vol. 229, no. 1, pp. 119–126, 2004.
[24] J. Legrand, R. Grais, P. Boelle, A. Valleron, and A. Flahault, “Understanding the dynamics of ebola
epidemics,” Epidemiology and infection, vol. 135, no. 04, pp. 610–621, 2007.
[25] P. E. Lekone and B. F. Finkensta¨dt, “Statistical inference in a stochastic epidemic seir model with
control intervention: Ebola as a case study,” Biometrics, vol. 62, no. 4, pp. 1170–1177, 2006.
[26] J. A. Lewnard, M. L. N. Mbah, J. A. Alfaro-Murillo, F. L. Altice, L. Bawo, T. G. Nyenswah, and A. P.
Galvani, “Dynamics and control of ebola virus transmission in montserrado, liberia: a mathematical
modelling analysis,” The Lancet Infectious Diseases, 2014.
[27] “UN Mission for Ebola Emergency Response (UNMEER), http://www.un.org/ebolaresponse/
mission.shtml,” October 1, 2014.
[28] R. Ndambi, P. Akamituna, M.-J. Bonnet, A. M. Tukadila, J.-J. Muyembe-Tamfum, and R. Cole-
bunders, “Epidemiologic and Clinical Aspects of the Ebola Virus Epidemic in Mosango, Democratic
Republic of the Congo, 1995,” The Journal of Infectious Diseases, vol. 179, pp. S8 – 10, 1999.
[29] US Centers for Disease Control and Prevention, “Ebola (Ebola Virus Disease), http://www.cdc.
gov/vhf/ebola/,” 2014.
[30] P. Francesconi, Z. Yoti, S. Declich, P. A. Onek, M. Fabiani, J. Olango, R. Andraghetti, P. E. Rollin,
C. Opira, D. Greco, and S. Salmaso, “Ebola Hemorrhagic Fever Transmission and Risk Factors of
Contacts, Uganda,” 2003.
[31] US Centers for Disease Control and Prevention, “Ebola Virus Disease Informa-
tion for Clinicians in U.S. Healthcare Settings, http://www.cdc.gov/vhf/ebola/hcp/
clinician-information-us-healthcare-settings.html (accessed dec 2014),” 2014.
[32] N. J. Beeching, M. Fenech, and C. F. Houlihan, “Ebola virus disease,” BMJ, vol. 349, p. g7348, 2014.
[33] M. Isaacson, P. Sureau, G. Courteille, and S. Pattyn, “Clinical aspects of ebola virus disease at the
ngaliema hospital, kinshasa, zaire, 1976,” Ebola virus haemorrhagic fever, pp. 15–20, 1978.
[34] O. Diekmann, J. Heesterbeek, and J. A. Metz, “On the definition and the computation of the basic
reproduction ratio r 0 in models for infectious diseases in heterogeneous populations,” Journal of
mathematical biology, vol. 28, no. 4, pp. 365–382, 1990.
[35] P. Van den Driessche and J. Watmough, “Reproduction numbers and sub-threshold endemic equilibria
for compartmental models of disease transmission,” Mathematical biosciences, vol. 180, no. 1, pp. 29–
48, 2002.
[36] The World Bank Group, “Estimates of total populations for Liberia, Guinea, and Sierra Leone,
http://data.worldbank.org/indicator/SP.POP.TOTL,” 2014.
[37] The MathWorks, Inc., Natick, Massachusetts, United States, “Matlab and statistics toolbox release
2014b.”
[38] A. A. King, M. D. de Celle`s, F. M. Magpantay, and P. Rohani, “Avoidable errors in the modeling
of outbreaks of emerging pathogens, with special reference to ebola,” Proc. R. Soc. B, vol. 282,
p. 20150347, 2015.
17
[39] S. F. Dowell, R. Mukunu, T. G. Ksiazek, A. S. Khan, P. E. Rollin, and C. Peters, “Transmission of
ebola hemorrhagic fever: a study of risk factors in family members, kikwit, democratic republic of the
congo, 1995,” Journal of Infectious Diseases, vol. 179, no. Supplement 1, pp. S87–S91, 1999.
[40] M. C. Eisenberg and M. A. Hayashi, “Determining identifiable parameter combinations using subset
profiling,” Mathematical biosciences, vol. 256, pp. 116–126, 2014.
[41] E. M. Landaw, B. C.-M. Chen, and J. J. Distefano III, “An algorithm for the identifiable parameter
combinations of the general mammillary compartmental model,” Mathematical biosciences, vol. 72,
no. 2, pp. 199–212, 1984.
[42] J. S. Weitz and J. Dushoff, “Modeling post-death transmission of ebola: Challenges for inference and
opportunities for control,” Scientific reports, vol. 5, 2015.
[43] Dave Johnson, Time Magazine, “Behind the Changing Forecast for Ebola Infections, http://time.
com/3627900/behind-the-changing-forecast-for-ebola-infections/,” Dec. 10, 2014.
[44] Carl Bialik, FiveThirtyEight, “We’ll Probably Never Know If The CDC’s
Grim Ebola Forecast Was Accurate, http://fivethirtyeight.com/datalab/
well-probably-never-know-if-the-cdcs-big-ebola-forecast-is-accurate/,” Sep. 25,
2014.
[45] D. Butler, “Models overestimate ebola cases,” Nature, vol. 515, no. 18, 2014.
[46] C. Rivers, “Ebola: models do more than forecast,” Nature, vol. 515, no. 492, 2014.
[47] G. Hooker, S. P. Ellner, L. D. V. Roditi, and D. J. Earn, “Parameterizing state–space models for
infectious disease dynamics by generalized profiling: measles in ontario,” Journal of The Royal Society
Interface, p. rsif20100412, 2010.
[48] N. D. Evans, L. J. White, M. J. Chapman, K. R. Godfrey, and M. J. Chappell, “The structural identi-
fiability of the susceptible infected recovered model with seasonal forcing,” Mathematical biosciences,
vol. 194, no. 2, pp. 175–197, 2005.
[49] J. D. Chapman and N. Evans, “The structural identifiability of susceptible–infective–recovered type
epidemic models with incomplete immunity and birth targeted vaccination,” Biomedical Signal
Processing and Control, vol. 4, no. 4, pp. 278–284, 2009.
[50] L. F. White, J. Wallinga, L. Finelli, C. Reed, S. Riley, M. Lipsitch, and M. Pagano, “Estimation of
the reproductive number and the serial interval in early phase of the 2009 influenza a/h1n1 pandemic
in the usa,” Influenza and other respiratory viruses, vol. 3, no. 6, pp. 267–276, 2009.
[51] B. Pourbohloul, A. Ahued, B. Davoudi, R. Meza, L. A. Meyers, D. M. Skowronski, I. Villasen˜or,
F. Galva´n, P. Cravioto, D. J. Earn, et al., “Initial human transmission dynamics of the pandemic
(h1n1) 2009 virus in north america,” Influenza and Other Respiratory Viruses, vol. 3, no. 5, pp. 215–
222, 2009.
[52] N. C. Grassly and C. Fraser, “Mathematical models of infectious disease transmission,” Nature
Reviews Microbiology, vol. 6, no. 6, pp. 477–487, 2008.
[53] M. C. Eisenberg, S. L. Robertson, and J. H. Tien, “Identifiability and estimation of multiple transmis-
sion pathways in cholera and waterborne disease,” Journal of theoretical biology, vol. 324, pp. 84–102,
2013.
[54] M. C. Eisenberg, G. Kujbida, A. R. Tuite, D. N. Fisman, and J. H. Tien, “Examining rainfall and
cholera dynamics in haiti using statistical and dynamic modeling approaches,” Epidemics, vol. 5,
no. 4, pp. 197–207, 2013.
18
[55] E. T. Lofgren, M. E. Halloran, C. M. Rivers, J. M. Drake, T. C. Porco, B. Lewis, W. Yang, A. Vespig-
nani, J. Shaman, J. N. Eisenberg, M. C. Eisenberg, M. Marathe, S. V. Scarpino, K. A. Alexander,
R. Meza, M. J. Ferrari, J. M. Hyman, L. A. Meyers, and S. Eubank, “Opinion: Mathematical models:
A key tool for outbreak response,” Proceedings of the National Academy of Sciences, vol. 111, no. 51,
pp. 18095–18096, 2014.
[56] M. A. Brookhart, A. E. Hubbard, M. J. van der Laan, J. M. Colford, and J. N. Eisenberg, “Statistical
estimation of parameters in a disease transmission model: analysis of a cryptosporidium outbreak,”
Statistics in Medicine, vol. 21, no. 23, pp. 3627–3638, 2002.
[57] J. H. Tien and D. J. Earn, “Multiple transmission pathways and disease dynamics in a waterborne
pathogen model,” Bulletin of mathematical biology, vol. 72, no. 6, pp. 1506–1533, 2010.
[58] M. H. Cortez and J. S. Weitz, “Distinguishing between indirect and direct modes of transmission
using epidemiological time series,” The American Naturalist, vol. 181, no. 2, pp. E43–E52, 2013.
19
6 Supplementary Information
6.1 Model Initial Conditions
The model initial conditions were determined as follows: for the measurement equations (Eq.
(3)), yC(0) and yD(0) were both set equal to the initial values of the data set being fitted; I2(0)
was approximated by examining the number of new deaths reported in the next two days after
the first data point (as these would have been in I2 when t = 0), and then re-scaling this quantity
from numbers of individuals to fraction of the population using k and N ; I1(0) was approximated
by evaluating the number of cases that had been reported in the past six days (as these would,
on average, still be in I1) and then re-scaling as for I2; F (0) was approximated by the re-scaled
number of deaths reported within the previous two days; R(0) was approximated roughly by
taking the number of incident cases in the last 15 days, subtracting the number of dead in the
last 15 days, and then re-scaling to fractions of the population; E(0) was taken as twice the
initial values for infectious individuals. S(0) was then calculated as 1 minus the remaining model
variable initial values. These initial conditions were quite rough (reflecting the uncertainty in the
data as well), but we tested a wide range of initial conditions based on differing assumptions and
also sampled within realistic ranges for the initial conditions; we found that the model fit well to
the data (with similar residual sum of squares values) for all initial condition values we set.
6.2 Additional Information on Parameter Estimates and Uncertainty
The non-fitted, LH-sampled parameter values associated with the best-fit trajectories in Figure
3 were:
• All countries: α = 0.1, β2/β1 = 3.38, βF /β1 = 3.44, δ2 = 0.99, γF = 0.36, γ2 = 0.53,
γ1 = 0.19, k = 0.0026
• Guinea: α = 0.11, β2/β1 = 2.04, βF /β1 = 2.63, δ2 = 0.99, γF = 0.40, γ2 = 0.92, γ1 = 0.19,
k = 0.0006
• Liberia: α = 0.11, β2/β1 = 4.90, βF /β1 = 3.84, δ2 = 0.93, γF = 0.35, γ2 = 0.96, γ1 = 0.20,
k = 0.0024
• Sierra Leone: α = 0.10, β2/β1 = 1.73, βF /β1 = 2.97, δ2 = 0.92, γF = 0.38, γ2 = 0.73,
γ1 = 0.15, k = 0.68
where the corresponding fitted values for β1 and δ are given in Table 2. We note that as these
parameters were LH-sampled rather than estimated there may be many other parameter values
which yield the same fit to the data. Figure S1 shows histograms of the goodness of fit scores
associated with all trajectories in Figure 3.
For the all countries combined case, we also examined the best 10% of fits (evaluated by their
sum of squares value), with the range (min to max) of these best fits shown in red shading in
Figure S2. These best 10% of fits tended to cluster around the overall best fit line (red line in
Fig. S2). Figure S3 shows histograms of the fitted (β1 and δ) and LH-sampled parameter values
corresponding to the best 10% of fits, and a histogram of the corresponding sum-of-squares values.
These histograms can help to give a sense of what parameter values yield the overall best fits to
the data. As shown in Figure S3, most non-fitted parameters span the full range of biologically
reasonable values in Table 1, even when only the best 10% of fits are considered, suggesting they
are likely to be practically unidentifiable. However, some parameters do appear to be primarily
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Figure S1: Histogram of residual sum of squares values for the simplified model fits to data from (left to
right): all countries combined, Guinea, Liberia, and Sierra Leone (corresponding to Figure 3).
drawn from specific regions, e.g. α, γ1, and the fitted parameters β1 and δ. We note that while k
shows only a weak tendency towards the small values seen in the best fit, the very lowest sum of
squares values consistently had low values for k, while the remaining parameters tended to cover
the same ranges seen in Figure S3.
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Figure S2: Model fits to data from all countries combined (as in Figure 3), with the region covered by the
best 10% of all fits (lowest residual sum of squares) highlighted with red shading.
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Figure S3: Histograms of the residual sum of squares (RSS, top) and parameter values (bottom) from the
best 10% of all fits (lowest residual sum of squares) for all countries combined (Fig. 3). While in some
cases, the best-fit parameters tend to be clustered at a particular values, others span the full range of
realistic values given in Table 1.
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R0 R1 R2 RF
All countries 1.6 (1.43 - 1.64)
0.58 (0.45 - 1.0) 0.41 (0.10 - 0.61) 0.61 (0.22 - 0.86)
36% (30% - 69%) 26% (7% - 40%) 38% (14% - 56%)
Guinea 1.79 (1.47 - 1.79)
0.86 (0.41 - 1.0) 0.23 (0.12 - 0.70) 0.69 (0.26 - 0.97)
48% (26% - 63%) 13% (7% - 43%) 39% (16% - 57%)
Liberia 1.81 (1.34 - 2.75)
0.60 (0.38 - 0.99) 0.41 (0.11 - 0.70) 0.81 (0.24 - 1.1)
33% (28% - 62%) 22% (8% - 47%) 45% (16% - 57%)
Sierra Leone 1.32 (1.19 - 1.37)
0.84 (0.49 - 0.96) 0.12 (0.065 - 0.41) 0.36 (0.15 - 0.55)
64% (39% - 75%) 9% (5% - 34%) 27% (12% - 44%)
Table S1: Overall best estimates and ranges for R0, and the contribution to R0 by I1, I2, and F (denoted
R1, R2, and RF respectively), as both magnitude and percentage of overall R0.
6.3 Transmission by Stage of Infection
We also examined the contributions of each stage of EVD to transmission. The model R0 breaks
up naturally into terms for each of the three stages (with each term in Eq. (2) corresponding
to I1, I2, and F ), representing the relative contributions of each transmission stage to R0. Each
term can be interpreted as the average number of secondary cases generated by an infectious
individual while in a particular stage of transmission. We denote each of these terms as R1, R2,
and RF respectively. Table S1 shows the contributions to R0 by each stage. In all cases, all three
transmission stages contributed to R0, with I1 and F tending to make the largest contributions
to R0. The estimated ranges of contribution by each stage are quite wide, likely due to the
unidentifiability issues for the transmission parameters by stage as noted above. Indeed, even if
only the best 10% of fits are considered, we still found wide ranges of contributions by stage, as
shown for all countries combined in Figure S4.
The result that the first stage may contribute strongly to R0 is somewhat counterintuitive
given the lower excretion of body fluids and lower viral load in the first few days of symptoms
compared to late-stage infection. Studies during previous outbreaks have observed cases occurring
after exposure during the first stage of disease [39], and have shown significant transmission risk
in the first stage [30]. In this model, the first stage is 1.5-5 times less transmissible, however
it lasts a longer period of time, and at each subsequent stage some fraction of people recover
(and so don’t continue to transmit), which lends the first stage a stronger impact on the overall
R0. Moreover, as individuals may be more likely to seek care as symptoms progress, late-stage
individuals may generate fewer cases due to reduced contact once hospitalized as well. However,
the relative contribution of the first stage to transmission would likely drop considerably if the
ranges for β2/β1 or βF /β1 were extended above the upper limit of 5 in Table 1, since similar
fits and forecasts were obtained across the full range of values. Because of the unidentifiabilities
in the transmission parameters of our model, without additional biological knowledge or data,
it is difficult or impossible to determine what the bounds of the biological ranges should be, or
estimate precisely where within the ranges shown in Table S1 the contribution of each stage to
R0 actually sits.
Nonetheless, in many of our simulations across these ranges, even complete elimination of any
single stage of transmission was not enough to reduce R0 below one, suggesting that interventions
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Figure S4: Histograms of R0 contributions by stage from the best 10% of all fits (lowest residual sum of
squares) for all countries combined (Figure 3). The top row shows contributions by stage as a percentage
of overall R0, while the bottom row shows the magnitudes of R1, R2, and RF (the contributions of I1, I2,
and F respectively). Even among the best fit estimates, the contributions by stage to R0 span from quite
low to the majority of transmission for any given stage, making it difficult to estimate the true contribution
of each stage to transmission from incidence data alone.
should target more than just the second stage to be fully effective (or indeed any other single
stage), and highlighting the importance of earlier case-finding and reducing funeral transmission.
These results underscore the importance of a wide range of intervention strategies, including
behavior and community-based interventions such as improving hygiene, sanitation, contact re-
duction with early stage infected, and safe burials, as well as collection of additional data on each
infection stage to transmission.
6.4 Expanded Forecasting Simulations
Figure S5 shows expanded forecasting simulations for each country and all countries combined,
using fixed parameter values at the midpoints of the ranges in Table 1, with β1, δ and k fitted to
the data using least squares. Figures S6 and S7 show analogous forecasts but with k fixed equal to
1 or 1/2.5, to represent either perfect reporting and complete population at risk, or a correction
only for underreporting using the estimates in [6]. The corresponding parameter estimates for
each fitted trajectory are given in Tables S2, S3, and S4.
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Figure S5: Multiple model fits and forecasts for each country individually and all countries combined, with
β1, δ, and k fitted to data, and the remaining parameters fixed to the midpoints of the ranges in Table 1.
The model fits (solid lines) use the data up through July 1 (red), August 1 (orange), September 1 (yellow),
October 1 (green), November 1 (blue) and December 1 (purple), with subsequent two months of forecasts
shown as dashed lines in the same color.
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Figure S6: Multiple model fits and forecasts for each country individually and all countries combined, with
β1 and δ fitted to data, and k fixed to 1 (equivalent to not including k in the model). The remaining
parameters fixed to the midpoints of the ranges in Table 1. The model fits (solid lines) use the data up
through July 1 (red), August 1 (orange), September 1 (yellow), October 1 (green), November 1 (blue) and
December 1 (purple), with subsequent two months of forecasts shown as dashed lines in the same color.
Note the difference in y-axis scale from Figure S5.
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Figure S7: Multiple model fits and forecasts for each country individually and all countries combined, with
β1 and δ fitted to data, and k fixed to 1/2.5 (based on the reporting rate estimate in [6]). The remaining
parameters fixed to the midpoints of the ranges in Table 1. The model fits (solid lines) use the data up
through July 1 (red), August 1 (orange), September 1 (yellow), October 1 (green), November 1 (blue) and
December 1 (purple), with subsequent two months of forecasts shown as dashed lines in the same color.
Note the difference in y-axis scale from Figure S5.
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Using data All countries Guinea Liberia Sierra Leone
through: β1 δ k β1 δ k β1 δ k β1 δ k
July 1, 2014 0.14 0.69 0.26 – – – – – – 0.067 0.37 0.34
Aug 1, 2014 0.12 0.67 0.31 0.13 0.97 0.24 – – – 0.10 0.51 0.63
Sep 1, 2014 0.13 0.64 0.38 0.13 0.75 0.46 0.11 0.79 0.17 0.11 0.49 0.46
Oct 1, 2014 0.14 0.57 0.0018 0.24 0.64 0.0002 0.16 0.65 0.0021 0.13 0.37 0.43
Nov 1, 2014 0.14 0.51 0.0018 0.20 0.59 0.0003 0.16 0.57 0.0025 0.13 0.36 0.71
Dec 1, 2014 0.16 0.43 0.0015 0.19 0.60 0.0003 0.16 0.48 0.0029 0.15 0.28 0.073
Table S2: Parameter estimates for each fit in Figure S5, with k included in the fitted parameters. Each
model is fitted to the data up through the dates given on the left.
Using data All countries Guinea Liberia Sierra Leone
through: β1 δ β1 δ β1 δ β1 δ
July 1, 2014 0.14 0.69 – – – – 0.067 0.37
Aug 1, 2014 0.12 0.67 0.13 0.97 – – 0.10 0.51
Sep 1, 2014 0.13 0.64 0.13 0.75 0.11 0.79 0.11 0.49
Oct 1, 2014 0.13 0.58 0.13 0.69 0.12 0.68 0.13 0.37
Nov 1, 2014 0.13 0.53 0.12 0.64 0.11 0.60 0.13 0.36
Dec 1, 2014 0.14 0.45 0.11 0.66 0.12 0.51 0.14 0.28
Table S3: Parameter estimates for each fit in Figure S6, with k fixed equal to 1 in all cases. Each model
is fitted to the data up through the dates given on the left.
Using data All countries Guinea Liberia Sierra Leone
through: β1 δ β1 δ β1 δ β1 δ
July 1, 2014 0.14 0.68 – – – – 0.067 .37
Aug 1, 2014 0.12 0.67 0.13 0.97 – – 0.10 0.51
Sep 1, 2014 0.13 0.64 0.13 0.75 0.11 0.79 0.11 0.49
Oct 1, 2014 0.13 0.58 0.13 0.69 0.12 0.68 0.13 0.37
Nov 1, 2014 0.13 0.53 0.12 0.64 0.11 0.60 0.13 0.36
Dec 1, 2014 0.14 0.45 0.11 0.66 0.12 0.50 0.14 0.28
Table S4: Parameter estimates for each fit in Figure S7, with k fixed equal to 0.4 in all cases. Each model
is fitted to the data up through the dates given on the left.
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